DCF — SENTARA NORTHERN VIRGINIA MED CTR
Enterprise Value: $-225.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-225.1M
Enterprise Value
$-76.4M
PV of Cash Flows
$-148.7M
PV of Terminal Value
$-239.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $294.9M | $-11.2M | -4.0% | $-23.7M | $-21.5M |
| Year 2 | $303.7M | $-8.5M | -3.0% | $-21.3M | $-17.6M |
| Year 3 | $312.8M | $-5.6M | -2.0% | $-18.9M | $-14.2M |
| Year 4 | $322.2M | $-4.2M | -1.0% | $-17.8M | $-12.2M |
| Year 5 | $331.9M | $-3.5M | -1.0% | $-17.5M | $-10.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-225.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$286.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.042959846539825076
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5